Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial

Background: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. Methods: The CRASH-3 trial random...

詳細記述

書誌詳細
出版年:Critical Care
第一著者: Brenner A.; Belli A.; Chaudhri R.; Coats T.; Frimley L.; Jamaluddin S.F.; Jooma R.; Mansukhani R.; Sandercock P.; Shakur-Still H.; Shokunbi T.; Roberts I.
フォーマット: 論文
言語:English
出版事項: BioMed Central Ltd 2020
オンライン・アクセス:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095781531&doi=10.1186%2fs13054-020-03243-4&partnerID=40&md5=15c5815a3482e941f90ef01220ef9d47